The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Posted 01 June 2011 | By
The US Food and Drug Administration (FDA) has proposed amending existing regulations to prevent disqualified investigators from conducting any type of agency-regulated clinical investigations. Currently, a disqualified investigator may still run clinical investigations with other types of products besides the type for which he or she was disqualified. For example, if an investigator is disqualified from running a trial on pharmaceuticals, they may still run trials on medical devices.